Welcome to the e-CCO Library!

P707: Microbial signature of the colon is not associated with response to vedolizumab in Crohn’s disease
Year: 2022
Source: ECCO'22
Authors: HagemanMD, I.(1,2);Joustra, V.(1);Li Yim, A.(2,3);Davids, M.(4);Henneman, P.(3);Hakvoort, T.(2);Probert, F.(5);Satsangi, J.(6);D'Haens, G.(1);De Jonge, W.(2);
Created: Friday, 11 February 2022, 3:56 PM
P707: Paediatric IBD patients do not meet the daily recommendations of vitamin D and calcium intake: survey based analysis in a tertiary centre
Year: 2017
Source: ECCO '17 Barcelona
Authors:

Shergill-Bonner R., Zambrano Perez A., Acton N., Chadokufa S., Huggett B., Kiparissi F., Baycheva M., Shah N., Sider S.

Created: Wednesday, 20 February 2019, 10:36 AM
P707: Using urgent small bowel ultrasound (SBUS) as a tool for decision-making in patients with inflammatory bowel disease (IBD): retrospective analysis of United Kingdom (UK) patients' outcome.
Year: 2023
Source: ECCO’23 Copenhagen
Authors: Lehmann, A.(1)*;Nandra, G.(2);Power, N.(2);Lindsay, J.O.(1);
Created: Friday, 14 July 2023, 11:12 AM
P708 The effect of psychotherapy on quality of life in inflammatory bowel disease patients: A systematic literature review
Year: 2020
Source:

ECCO'20 Vienna

Authors:

E. Paulides1,2, I. Boukema2, C.J. van der Woude1, N.K.H. de Boer2

Created: Thursday, 30 January 2020, 10:12 AM
P708: Helicobacter pylori and IBD are inversely related, suggesting that individuals infected with the bacteria are less susceptible to the disease
Year: 2017
Source: ECCO '17 Barcelona
Authors:

Lichtenstein L.*1, Boltin D.1, Leibovici H.1, Tsadok Perets T.2, Avni I.1, Comaneshter D.3, Leibovici-Weissman Y.1, Cohen A.3, Niv Y.1,4, Levi Z.1,4

Created: Wednesday, 20 February 2019, 10:36 AM
P708: Home-based infusion therapy for biologic agent administration as a therapeutic option for patients with inflammatory bowel disease
Year: 2018
Source: ECCO '18 Vienna
Authors:

M. Madden, S. S. R. Pulusu*, I. Lawrance

Created: Thursday, 21 February 2019, 9:14 AM
P708: Ileal involvement defined by Montreal classification in Crohn’s disease is associated with a distinct microbial composition in ileal and colonic mucosa
Year: 2022
Source: ECCO'22
Authors: Hernandez-Rocha, C.(1);Nayeri, S.(1);Turpin, W.(1);Borowski, K.(1);Stempak, J.(1);Silverberg, M.S.(1);
Created: Friday, 11 February 2022, 3:56 PM
P708: Post-COVID-19 and Quality of Life in Patients with Immune Mediated Inflammatory Diseases
Year: 2023
Source: ECCO’23 Copenhagen
Authors: Schlosser, T.(1)*;Krasselt , M.(2);Elsing, L.(1);Hecker, M.(1);Holler, B.(1);Hoffmeister, A.(1);
Created: Friday, 14 July 2023, 11:12 AM
P708: Prospective study to predict psychological morbidity in young people with inflammatory bowel disease using novel risk assessment tool
Year: 2019
Source:

ECCO '19 Copenhagen

Authors:

A. Hoogkamer*1, A. Brooks1, G. Rowse2, P. Norman2, A. Lobo1

Created: Friday, 22 February 2019, 9:41 AM
P709 Is azathioprine safe as long-term treatment in paediatric patients with inflammatory bowel disease?
Year: 2020
Source:

ECCO'20 Vienna

Authors:

M.A. Martínez Ibeas, I. Bacelo Ruano, S. Rodríguez Manchón, M. Velasco Rodríguez-Belvís, J.F. Viada Bris, G. Domínguez Ortega, R.A. Muñoz Codoceo

Created: Thursday, 30 January 2020, 10:12 AM
P709: Distinct Pattern of Gut Microbial Dysbiosis in Crohn's Disease and Intestinal Tuberculosis - A Machine Learning-based classification model
Year: 2022
Source: ECCO'22
Authors: Markandey, M.(1);Bajaj, A.(1);Vuyyuru, S.K.(1);Mohta, S.(1);Singh, M.(1);Verma, M.(1);Kumar, S.(1);Kante, B.(1);Kumar, P.(1);Makharia, G.(1);Kedia, S.(1);Ahuja, V.(1);
Created: Friday, 11 February 2022, 3:56 PM
P709: Early measurement of serum cytokines as predictor of clinical and endoscopic outcome to vedolizumab in patients with ulcerative colitis
Year: 2019
Source:

ECCO '19 Copenhagen

Authors:

L. Bertani*1, L. Antonioli2, L. Baglietto2, G. Tapete1, E. Albano1, M. G. Mumolo3, L. Ceccarelli3, S. Maltinti1, M. Fornai2, S. Marchi1, C. Blandizzi2, F. Costa3

Created: Friday, 22 February 2019, 9:41 AM
P709: Endoscopic healing and clinical remission after administration of adalimumab to patients with Crohn's disease of the small intestine
Year: 2023
Source: ECCO’23 Copenhagen
Authors: Viazis, N.(1)*;Koustenis, K.(1);Veretanos, C.(1);Mountaki, A.(1);Almpani, F.(1);Tsatsa, A.(1);Trikola, A.(1);Beka, H.(1);Arvanitis, K.(1);Georgiadi, T.(1);Nousias, G.(1);Mylonas, I.(1);Kozompoli, D.(1);Paparizou, N.(1);Karaouzas, L.(1);Papastergiou, V.(1);Archavlis, E.(1);Mela , M.(1);Christidou, A.(1);Varytimiadis , K.(1);Hatzievangelinou, C.(1);Katopodi, K.(1);Vienna, E.(1);Mantzaris, G.(1);
Created: Friday, 14 July 2023, 11:12 AM
P709: inflammatory bowel disease and colorectal cancer: analysis of a single center retrospective chart review
Year: 2017
Source: ECCO '17 Barcelona
Authors:

Fragaki M., Bachlitzanaki M., Karmiris K., Theodoropoulou A., Vardas E., Paspatis G.

Created: Wednesday, 20 February 2019, 10:36 AM
P709: Is there a difference in adalimumab drug levels according to pen vs. syringe use: An international, multi-centre retrospective analysis
Year: 2018
Source: ECCO '18 Vienna
Authors:

R. Little1*, I. Chu1, E. van der Zanden2, E. Flanagan3, S. Bell3, M. Sparrow1, E. Shelton4, S. Connor2, X. Roblin5, M. Ward1

Created: Thursday, 21 February 2019, 9:14 AM
P710 The influence of probiotics to the efficacy of 5-ASA for the patients of ulcerative colitis
Year: 2020
Source:

ECCO'20 Vienna

Authors:

R. YASUDA, K. Uchiyama, T. Takagi, M. Kubota, S. Sugino, Y. Azuma, H. Kitae, T. Torii, S. Takayama, K. Inoue, K. Katada, K. Kamada, T. Ishikawa, H. Konishi, Y. Naito, Y. Itoh

Created: Thursday, 30 January 2020, 10:12 AM
P710: Changes of gut microbiome after anti-TNF-α therapy and the prediction of clinical remission in patients with active ulcerative colitis
Year: 2023
Source: ECCO’23 Copenhagen
Authors: ShinShin, S.(1)*;Oh, H.N.(2);Moon, J.M.(1);Joo, H.J.(1);Sul, W.J.(2);Choi, C.H.(1);
Created: Friday, 14 July 2023, 11:12 AM
P710: Efficacy of therapeutic intervention for ulcerative colitis patients with the Mayo Endoscopic Score of 1
Year: 2018
Source: ECCO '18 Vienna
Authors:

T. Fukuda1*, M. Naganuma1, S. Sugimoto1, K. Ono1, K. Nanki1, S. Mizuno1, K. Kimura2, M. Mutaguchi1, K. Takabayashi2, N. Inoue3, H. Ogata2, Y. Iwao3, T. Kanai1

Created: Thursday, 21 February 2019, 9:14 AM
P710: The use of first-line biologics in patients with Crohn’s disease in Norway from 2011 to 2016
Year: 2019
Source:

ECCO '19 Copenhagen

Authors:

K. Anisdahl*1,2, S. Lirhus3, A. Medhus1, L. Buer1,2, H. O. Melberg3, B. Moum1,2, M. Lie Høivik1

Created: Friday, 22 February 2019, 9:41 AM